The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed on Thursday, dampening expectations for the closely watched drug.
A draft summary went online briefly on the WHO Web site and was first reported by the Financial Times and health news Web site Stat, which posted a screenshot.
However, Gilead Sciences, the company behind the medicine, disputed how the now-deleted post had characterized the findings, saying that the data showed a “potential benefit.”
Photo: AFP
The Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group, the summary said, adding that remdesivir was stopped early in 18 patients because of side effects.
The authors said that remdesivir was “not associated with a difference in time to clinical improvement” compared with the control.
After a month, 13.9 percent of the patients on remdesivir had died, compared with 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
“We believe the post included inappropriate characterizations of the study,” a Gilead spokesman told reporters, adding that it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the spokesman said.
The study does not represent the final word on the matter, and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported that it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes of Health also reported it that had proven effective in a small experiment on monkeys.
Remdesivir, which previously failed in trials against Ebola, belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes. It mimics one of the four building blocks of RNA and DNA, and gets absorbed into the virus’ genome, which in turn stops the pathogen from replicating.
Anti-malarial drugs hydroxychloroquine and chloroquine have also been widely used on COVID-19 on a so-called “compassionate basis” pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from COVID-19 survivors and injecting them in patients, or harvesting antibodies from genetically engineered mice that were deliberately infected.
Separately in France, new research shows that nicotine could protect people from contracting COVID-19.
The findings came after researchers at a top Paris hospital examined 343 COVID-19 patients, as well as 139 people with the illness who had milder symptoms.
They found that a low number of them smoked, compared with smoking rates of about 35 percent in France’s general population.
“Among these patients, only 5 percent were smokers,” said Zahir Amoura, the study’s coauthor and a professor of internal medicine.
The research echoed similar findings published in the New England Journal of Medicine last month suggesting that 12.6 percent of 1,000 people infected in China were smokers.
That was a much lower figure than the number of regular smokers in China’s general population, about 26 percent, WHO data showed.
The theory is that nicotine could adhere to cell receptors, therefore blocking the novel coronavirus from entering cells and spreading in the body, said neurobiologist Jean-Pierre Changeux from France’s Pasteur Institute, who also coauthored the study.
The researchers are awaiting approval from health authorities to carry out further clinical trials.
The researchers are looking into whether nicotine could help to prevent “cytokine storms,” a rapid overreaction of the immune system that scientists think could play a key role in fatal COVID-19 cases.
However, with further research needed, experts are not encouraging people to pick up smoking or use nicotine patches as a protective measure against the virus.
“We must not forget the harmful effects of nicotine,” French Director-General for Health Jerome Salomon said.
“Those who do not smoke should absolutely not use nicotine substitutes,” which cause side effects and addiction, he said.
Tens of thousands of Filipino Catholics yesterday twirled white cloths and chanted “Viva, viva,” as a centuries-old statue of Jesus Christ was paraded through the streets of Manila in the nation’s biggest annual religious event. The day-long procession began before dawn, with barefoot volunteers pulling the heavy carriage through narrow streets where the devout waited in hopes of touching the icon, believed to hold miraculous powers. Thousands of police were deployed to manage crowds that officials believe could number in the millions by the time the statue reaches its home in central Manila’s Quiapo church around midnight. More than 800 people had sought
DENIAL: Pyongyang said a South Korean drone filmed unspecified areas in a North Korean border town, but Seoul said it did not operate drones on the dates it cited North Korea’s military accused South Korea of flying drones across the border between the nations this week, yesterday warning that the South would face consequences for its “unpardonable hysteria.” Seoul quickly denied the accusation, but the development is likely to further dim prospects for its efforts to restore ties with Pyongyang. North Korean forces used special electronic warfare assets on Sunday to bring down a South Korean drone flying over North Korea’s border town. The drone was equipped with two cameras that filmed unspecified areas, the General Staff of the North Korean People’s Army said in a statement. South Korea infiltrated another drone
COMMUNIST ALIGNMENT: To Lam wants to combine party chief and state presidency roles, with the decision resting on the election of 200 new party delegates next week Communist Party of Vietnam General Secretary To Lam is seeking to combine his party role with the state presidency, officials said, in a move that would align Vietnam’s political structure more closely to China’s, where President Xi Jinping (習近平) heads the party and state. Next week about 1,600 delegates are to gather in Hanoi to commence a week-long communist party congress, held every five years to select new leaders and set policy goals for the single-party state. Lam, 68, bade for both top positions at a party meeting last month, seeking initial party approval ahead of the congress, three people briefed by
Indonesia and Malaysia have become the first countries to block Grok, the artificial intelligence (AI) chatbot developed by Elon Musk’s xAI, after authorities said it was being misused to generate sexually explicit and nonconsensual images. The moves reflect growing global concern over generative AI tools that can produce realistic images, sound and text, while existing safeguards fail to prevent their abuse. The Grok chatbot, which is accessed through Musk’s social media platform X, has been criticized for generating manipulated images, including depictions of women in bikinis or sexually explicit poses, as well as images involving children. Regulators in the two Southeast Asian
RSS